Todd C. Davis
Chief Executive Officer, Director · LIGAND PHARMACEUTICALS INC
- 2024
- Jul 6, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Todd C. Davis files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Octavio Espinoza - $13.03M in LGND purchases and sales in the last 12 months
- Andrew Reardon - $10.29M in LGND purchases and sales in the last 12 months
- George M. Jenkins - $8.30M in PVLA purchases and sales in the last 12 months
- Kathleen Goin - $5.63M in PVLA purchases and sales in the last 12 months
- Jason Haas - $3.74M in LGND purchases and sales in the last 12 months
- John L. Lamattina - $2.44M in LGND purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Todd C. Davis?
Todd C. Davis is a corporate insider, tracked as Chief Executive Officer, Director of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Todd C. Davis last file a Form 4?
The most recent primary Form 4 on record is dated 6 July 2026, one of 11 filings going back to 2024.
Has Todd C. Davis been buying or selling stock?
Recorded transactions: 2 open-market purchases ($1000K) and 0 open-market sales across all tracked filings.
